drugset / Trial / NCT01676987
Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy and safety of a fixed-dose, single-capsule budesonide(400µg)-formoterol(12µg) combination, in comparison with budesonide alone, both delivered via a dry powder inhaler, in 181 patients with uncontrolled asthma.This was Randomized, double-blind, multicenter, phase III, parallel clinical trial.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-09
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 400 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |